DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 1404


Antibody Investigational Unknown Unknown Lung Neoplasms; Multiple Myeloma; Neoplasms; Sarcoma; Sarcoma, Ewing; Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell Insulin-like growth factor I receptor antagonist


Antibody Investigational Unknown Unknown Lymphoma, Non-Hodgkin; Lymphoma T-lymphocyte activation antigen CD80 inhibitor


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Ascites; Carcinoma, Pancreatic Ductal; Digestive System Neoplasms; Endometrial Neoplasms; Leukemia; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Adenocarcinoma of Lung; Astrocytoma; Biliary Tract Neoplasms; Carcinoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Glioblastoma; Granuloma, Lethal Midline; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Nasopharyngeal Neoplasms; Oligodendroglioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Rectal Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasms; Stomach Neoplasms Programmed cell death protein 1 inhibitor

Antibody

Investigational

Unknown

Ascites; Carcinoma, Pancreatic Ductal; Digestive System Neoplasms; Endometrial Neoplasms; Leukemia; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Adenocarcinoma of Lung; Astrocytoma; Biliary Tract Neoplasms; Carcinoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Glioblastoma; Granuloma, Lethal Midline; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Nasopharyngeal Neoplasms; Oligodendroglioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Rectal Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasms; Stomach Neoplasms

Programmed cell death protein 1 inhibitor


Antibody Unknown Unknown Unknown COVID-19; Severe Acute Respiratory Syndrome Spike glycoprotein blocker


Antibody Investigational Unknown Unknown Astrocytoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioma; Gliosarcoma; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Oligodendroglioma; Sarcoma; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Choriocarcinoma; Gestational Trophoblastic Disease; Glioblastoma; Macular Degeneration; Prostatic Neoplasms, Castration-Resistant; Trophoblastic Tumor, Placental Site; Hemangiosarcoma Endoglin inhibitor

Antibody

Investigational

Unknown

Astrocytoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioma; Gliosarcoma; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Oligodendroglioma; Sarcoma; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Choriocarcinoma; Gestational Trophoblastic Disease; Glioblastoma; Macular Degeneration; Prostatic Neoplasms, Castration-Resistant; Trophoblastic Tumor, Placental Site; Hemangiosarcoma

Endoglin inhibitor


Antibody Investigational Unknown Unknown Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms Epidermal growth factor receptor erbB1 antagonist


Antibody Investigational Unknown Unknown Unknown Carbonic anhydrase IX binding agent


Antibody Investigational Unknown Unknown Colitis, Ulcerative; Crohn Disease Mucosal addressin cell adhesion molecule-1 inhibitor


Antibody Investigational Unknown Unknown Breast Neoplasms; Endometrial Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms Folate receptor alpha binding agent


Antibody Investigational Unknown Unknown Unknown Urushiol inhibitor


Antibody Investigational Unknown Unknown COVID-19; Severe Acute Respiratory Syndrome Spike glycoprotein inhibitor


Antibody Investigational Unknown Unknown Metabolic Diseases; Hypertriglyceridemia; Cardiovascular Diseases; Hypercholesterolemia; Hyperlipoproteinemia Type II Angiopoietin-related protein 3 inhibitor


Antibody Investigational Unknown Unknown Lymphoma HLA class II histocompatibility antigen, DRB1-15 beta chain other


Antibody Investigational Unknown Unknown Leukemia, Myelomonocytic, Chronic; Lymphoma, Follicular; Arthritis, Rheumatoid; Asthma; Pneumonia; Severe Acute Respiratory Syndrome Granulocyte-macrophage colony-stimulating factor inhibitor


Antibody Investigational Unknown Unknown Hodgkin Disease; Lymphoma, T-Cell, Cutaneous; Sarcoma, Kaposi; Hematologic Neoplasms; Lymphoma; Lymphoma, Large-Cell, Anaplastic Tumor necrosis factor receptor superfamily member 8 agonist


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Carcinoma, Pancreatic Ductal; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mouth Neoplasms; Pleural Effusion; Adenocarcinoma; Adenocarcinoma of Lung; Adrenal Cortex Neoplasms; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Granuloma, Lethal Midline; Hypopharyngeal Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Meningeal Carcinomatosis; Neoplasms; Osteosarcoma; Ovarian Neoplasms; Paranasal Sinus Neoplasms; Rectal Neoplasms; Sarcoma; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Neoplasms; Hodgkin Disease; Melanoma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms Programmed cell death protein 1 antagonist

Antibody

Investigational

Unknown

Carcinoma, Pancreatic Ductal; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mouth Neoplasms; Pleural Effusion; Adenocarcinoma; Adenocarcinoma of Lung; Adrenal Cortex Neoplasms; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Granuloma, Lethal Midline; Hypopharyngeal Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Meningeal Carcinomatosis; Neoplasms; Osteosarcoma; Ovarian Neoplasms; Paranasal Sinus Neoplasms; Rectal Neoplasms; Sarcoma; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Neoplasms; Hodgkin Disease; Melanoma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms

Programmed cell death protein 1 antagonist


Antibody Investigational Unknown Unknown Adenocarcinoma, Clear Cell; Glioblastoma; Breast Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cholangiocarcinoma; Melanoma; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Urinary Bladder Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Hodgkin Disease; Uterine Cervical Neoplasms Programmed cell death protein 1 inhibitor

Antibody

Investigational

Unknown

Adenocarcinoma, Clear Cell; Glioblastoma; Breast Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cholangiocarcinoma; Melanoma; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Urinary Bladder Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Hodgkin Disease; Uterine Cervical Neoplasms

Programmed cell death protein 1 inhibitor


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Diabetes Mellitus; Glomerulosclerosis, Focal Segmental; Hepatitis B, Chronic; Severe Acute Respiratory Syndrome; Idiopathic Pulmonary Fibrosis; Muscular Dystrophy, Duchenne; Pancreatic Neoplasms Connective tissue growth factor inhibitor


Antibody Unknown Unknown Unknown Myelodysplastic Syndromes; Primary Myelofibrosis; Neoplasms Unknown


Antibody Unknown Unknown Unknown Colorectal Neoplasms; Neoplasms; Adenocarcinoma; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholangiocarcinoma; Esophageal Neoplasms; Nasopharyngeal Carcinoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma Programmed cell death 1 ligand 1 inhibitor

Antibody

Unknown

Colorectal Neoplasms; Neoplasms; Adenocarcinoma; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholangiocarcinoma; Esophageal Neoplasms; Nasopharyngeal Carcinoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma

Programmed cell death 1 ligand 1 inhibitor


Antibody Investigational Unknown Unknown Lymphoma, Non-Hodgkin; Neuromyelitis Optica; Waldenstrom Macroglobulinemia; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting B-lymphocyte antigen CD20 binding agent


Antibody Investigational Unknown Unknown Unknown T-cell receptor antagonist


Antibody Investigational Unknown Unknown Unknown Unknown


Antibody Investigational Unknown Unknown Carcinoma, Squamous Cell; Neoplasms; Breast Neoplasms; Head and Neck Neoplasms; Hemangiosarcoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Receptor tyrosine-protein kinase erbB-3 inhibitor


Antibody Investigational Unknown Unknown Respiratory Syncytial Virus Infections Fusion glycoprotein F0 inhibitor


Antibody Investigational Unknown Unknown Renal Insufficiency, Chronic; Scleroderma, Systemic; Dermatitis, Atopic; Eczema; Prurigo Interleukin-31 receptor subunit alpha inhibitor


Antibody Investigational Unknown Unknown Alzheimer Disease Amyloid-beta A4 protein binding agent


Antibody Unknown Unknown Unknown Giant Cell Tumors Unknown


Antibody Investigational Unknown Unknown Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Neoplasms B-lymphocyte antigen CD20 binding agent


Antibody Investigational Unknown Unknown COVID-19; Severe Acute Respiratory Syndrome Spike glycoprotein inhibitor